Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893706380> ?p ?o ?g. }
- W2893706380 endingPage "608" @default.
- W2893706380 startingPage "597" @default.
- W2893706380 abstract "La efectividad del tratamiento del virus de la hepatitis C (VHC) parece ser menor en usuarios de drogas por vía parenteral (UDVP). Analizamos la influencia de diversos factores como los trastornos psiquiátricos y la terapia de sustitución con opiáceos (TSO) en el tratamiento con antivirales de acción directa (AAD) de este colectivo.Trescientos treinta y dos pacientes UDVP fueron tratados con AAD en 12 hospitales de España entre 2004 y 2020. Se catalogaron, si se disponía del dato, en consumidores recientes y pasados (según si el último consumo fue en los últimos 3 años) y se recogieron diversas variables, evaluándose la efectividad del tratamiento según la carga viral 12 semanas tras la finalización del tratamiento con el parámetro «respuesta viral sostenida» (RVS12).El 23,4% eran consumidores recientes y el 27,7% estaban en TSO. El 41,5% presentaban algún diagnóstico de enfermedad psiquiátrica. La RVS12 fue del 84,04%, ascendiendo al 96,21% al excluir del análisis a los pacientes que perdieron el seguimiento (12,7%). La RVS12 fue significativamente inferior debido a un aumento de la pérdida de seguimiento en consumidores recientes, aquellos en TSO, los que habían estado en prisión los últimos 5 años y pacientes naïve, así como en el trastorno de ansiedad generalizada y consumidores de benzodiacepinas.La efectividad del tratamiento del VHC con AAD en UDVP es similar a la población general si se consigue un adecuado seguimiento. Es importante realizar un seguimiento más estrecho en pacientes en TSO, consumidores recientes y aquellos con enfermedad psiquiátrica.The effectiveness of the hepatitis C virus (HCV) treatment seems to be lower in people who inject drugs (PWID). We analyze the influence of various factors as psychiatric disorders and opioid substitution therapy (OST) on the treatment with direct-acting antivirals (DAA) in this collective.Three hundred thirty-two PWID patients were treated with DAA in 12 Spanish hospitals between 2004 and 2020. They were catalogued in recent and former consumers (if the last consumption was in the last 3 years) and several variables were included, evaluating the effectiveness of the treatment according to the viral load 12 weeks after the end of the treatment with the parameter «sustained viral response» (SVR12).23.4% were recent consumers and 27.7% were on OST. The 41.5% had any diagnosis of psychiatric disorder. SVR12 was 84.04%, ascending to 96.21% when excluded from the analyses the patients lost to follow-up (12.7%). SVR12 was lower due to an increase in the loss to follow-up in recent consumers and other factors like OST, being in prison the last 5 years, naïve patients, generalized anxiety disorder and benzodiazepine consumption.The effectiveness of the HCV treatment with DAA in PWID is similar than in general population in patients whit an appropriate follow-up. It is important to maintain a closer follow-up in patients on OST, recent consumers and those with psychiatric disorders." @default.
- W2893706380 created "2018-10-05" @default.
- W2893706380 creator A5002853281 @default.
- W2893706380 creator A5013551077 @default.
- W2893706380 creator A5018736422 @default.
- W2893706380 creator A5032710486 @default.
- W2893706380 creator A5033012471 @default.
- W2893706380 creator A5037927976 @default.
- W2893706380 creator A5038008037 @default.
- W2893706380 creator A5041306394 @default.
- W2893706380 creator A5062157735 @default.
- W2893706380 creator A5070949389 @default.
- W2893706380 creator A5079557826 @default.
- W2893706380 creator A5083635002 @default.
- W2893706380 creator A5091796783 @default.
- W2893706380 date "2018-11-01" @default.
- W2893706380 modified "2023-10-08" @default.
- W2893706380 title "Guía de tratamiento de la infección por virus de la hepatitis C. Asociación Española para el Estudio del Hígado (AEEH)" @default.
- W2893706380 cites W1571790880 @default.
- W2893706380 cites W1881390415 @default.
- W2893706380 cites W1908153784 @default.
- W2893706380 cites W2081897332 @default.
- W2893706380 cites W2092646281 @default.
- W2893706380 cites W2094778224 @default.
- W2893706380 cites W2147326489 @default.
- W2893706380 cites W2159739349 @default.
- W2893706380 cites W2183784190 @default.
- W2893706380 cites W2185218296 @default.
- W2893706380 cites W2266909385 @default.
- W2893706380 cites W2282418649 @default.
- W2893706380 cites W2284028703 @default.
- W2893706380 cites W2289667014 @default.
- W2893706380 cites W2320330796 @default.
- W2893706380 cites W2325297898 @default.
- W2893706380 cites W2332403844 @default.
- W2893706380 cites W2335913920 @default.
- W2893706380 cites W2467146687 @default.
- W2893706380 cites W2467713285 @default.
- W2893706380 cites W2527946790 @default.
- W2893706380 cites W2546358667 @default.
- W2893706380 cites W2586826494 @default.
- W2893706380 cites W2605116305 @default.
- W2893706380 cites W2605698336 @default.
- W2893706380 cites W2613016777 @default.
- W2893706380 cites W2613143451 @default.
- W2893706380 cites W2613776086 @default.
- W2893706380 cites W2617500612 @default.
- W2893706380 cites W2618542764 @default.
- W2893706380 cites W2622058694 @default.
- W2893706380 cites W2739670275 @default.
- W2893706380 cites W2746084941 @default.
- W2893706380 cites W2748400966 @default.
- W2893706380 cites W2751450406 @default.
- W2893706380 cites W2756644889 @default.
- W2893706380 cites W2761085897 @default.
- W2893706380 cites W2768486652 @default.
- W2893706380 cites W2783536716 @default.
- W2893706380 cites W2788216918 @default.
- W2893706380 cites W2789396061 @default.
- W2893706380 cites W2789796276 @default.
- W2893706380 cites W2790614827 @default.
- W2893706380 cites W2792190643 @default.
- W2893706380 cites W2793581566 @default.
- W2893706380 cites W2801058713 @default.
- W2893706380 cites W2801721157 @default.
- W2893706380 cites W2809950681 @default.
- W2893706380 cites W2909893578 @default.
- W2893706380 doi "https://doi.org/10.1016/j.gastrohep.2018.07.010" @default.
- W2893706380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30270150" @default.
- W2893706380 hasPublicationYear "2018" @default.
- W2893706380 type Work @default.
- W2893706380 sameAs 2893706380 @default.
- W2893706380 citedByCount "14" @default.
- W2893706380 countsByYear W28937063802019 @default.
- W2893706380 countsByYear W28937063802020 @default.
- W2893706380 countsByYear W28937063802021 @default.
- W2893706380 countsByYear W28937063802022 @default.
- W2893706380 countsByYear W28937063802023 @default.
- W2893706380 crossrefType "journal-article" @default.
- W2893706380 hasAuthorship W2893706380A5002853281 @default.
- W2893706380 hasAuthorship W2893706380A5013551077 @default.
- W2893706380 hasAuthorship W2893706380A5018736422 @default.
- W2893706380 hasAuthorship W2893706380A5032710486 @default.
- W2893706380 hasAuthorship W2893706380A5033012471 @default.
- W2893706380 hasAuthorship W2893706380A5037927976 @default.
- W2893706380 hasAuthorship W2893706380A5038008037 @default.
- W2893706380 hasAuthorship W2893706380A5041306394 @default.
- W2893706380 hasAuthorship W2893706380A5062157735 @default.
- W2893706380 hasAuthorship W2893706380A5070949389 @default.
- W2893706380 hasAuthorship W2893706380A5079557826 @default.
- W2893706380 hasAuthorship W2893706380A5083635002 @default.
- W2893706380 hasAuthorship W2893706380A5091796783 @default.
- W2893706380 hasConcept C138885662 @default.
- W2893706380 hasConcept C15708023 @default.
- W2893706380 hasConcept C71924100 @default.
- W2893706380 hasConceptScore W2893706380C138885662 @default.
- W2893706380 hasConceptScore W2893706380C15708023 @default.
- W2893706380 hasConceptScore W2893706380C71924100 @default.